McKesson Corporation (MCK) Stock Analysis

McKesson Corporation (MCK) is a publicly traded company in the HEALTHCARE sector. It trades at $736.78, carries a market capitalization of $88.33B, a price-to-earnings ratio of 19.16. This page summarizes the public market data, fundamentals, and frequently asked questions for MCK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DISTRIBUTION

Exchange: NYSE

Key Metrics

• Price: $736.78
• Market Cap: $88.33B
• P/E Ratio: 19.16
• EPS: $38.36
• 52-Week High: $997.90
• 52-Week Low: $634.42

Market Sentiment

McKesson Corporation currently has a Neutral sentiment score of 0.09.

About McKesson Corporation

McKesson Corporation (MCK) stands as a preeminent leader in the American healthcare landscape, specializing in the distribution of pharmaceuticals and medical supplies while providing integrated healthcare management solutions. Leveraging advanced technology and a comprehensive service portfolio, McKesson enhances operational efficiency for healthcare providers, payers, and pharmaceutical manufacturers. Its strategic focus on innovation not only reinforces the company's competitive advantage ...

GNG Research Analysis

GNG Research scores McKesson Corporation (MCK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MCK.

Frequently Asked Questions

Does MCK pay dividends?

McKesson Corporation (MCK) does not currently pay a regular dividend.

What is MCK's P/E ratio?

McKesson Corporation has a price-to-earnings (P/E) ratio of 19.16.

What is MCK's market cap?

McKesson Corporation (MCK) has a market capitalization of $88.33B with a current stock price of $736.78.